BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 15, 2012
View Archived Issues
Genomic biomarker panel predicts COPD exacerbations
Read More
AstraZeneca and Dainippon Sumitomo Pharma present new TLR7 agonists
Read More
British group divulges new bifunctional agents
Read More
Lundbeck discloses new PDE10A inhibitors
Read More
Katholieke Universiteit Leuven patents novel agents for HIV
Read More
New phase II INNO-206 trial launched
Read More
Incyte synthesizes novel JAK-1 inhibitors
Read More
New biomarker panel discovered for use in spinal muscular atrophy research
Read More
LY-2881835 shows antidiabetic activity in vivo
Read More
Stratatech skin substitute receives FDA orphan drug status
Read More
New anticancer agents prepared by Indian company
Read More
Johnson & Johnson completes acquisition
Read More
Georgetown University presents novel ezrin inhibitors
Read More
MD Anderson Cancer Center joins phase I LOR-253 study
Read More
International team of researchers develops novel cancer treatments
Read More
GL-ONC1 combination study begins in advanced head and neck cancer
Read More
DreaMS study reveals benefit of ONO-4641
Read More
Research underlying BioLineRx project wins award
Read More
Innovimmune Biotherapeutics obtains NIH grant
Read More
Treatment begins in new Actimab-A study
Read More
Teva discloses topline data from phase III GALA trial
Read More
BrainStorm Cell Therapeutics receives grant for autologous adult stem cell product development
Read More
Theraclone product enters phase I testing for CMV infection
Read More
Data and safety monitoring board recommends continuation of vosaroxin trial
Read More
Phase II oregovomab study in ovarian cancer opens in U.S.
Read More
PharmAthene advances development of anthrax vaccine
Read More
Phase II results reported for oral interferon alpha in hepatitis C
Read More
FDA approves MenHibrix
Read More